To comprehensively analyze existing evidence, we systematically searched PubMed and Web of Science using the following keyword combinations: ferroptosis AND (central nervous system injury)/ferroptosis AND (central nervous system damage)/ferroptosis AND (central nervous system disease)/ferroptosis AND (neurodegenerative diseases)/ferroptosis AND [(Parkinsons disease) OR (Alzheimers disease) OR (Huntingtons disease) OR (multiple sclerosis)]/ferroptosis AND [(subarachnoid hemorrhage) OR (SAH)]/ferroptosis AND [(traumatic brain injury) OR TBI OR (head injury)]/ferroptosis AND [stroke OR (cerebral hemorrhage)]/ferroptosis AND (spinal cord injury)
Additionally, there is a remarkable need for clinical research to study the effect of the dose and duration of the supplementation on the efficacy of nutritional interventions

Ingredients: Galactomyces Ferment Filtrate, Glycerin, Cetyl Ethylhexanoate, Propanediol, Dicaprylyl Carbonate, 1,2-Hexanediol, Betaine, Cetearyl Alcohol, Polyglyceryl-10 Laurate, Methyl Trimethicone, Silica, Cetearyl Olivate, Panthenol, Phenyl Trimethicone, Potassium Cetyl Phosphate, Water, Sorbitan Olivate, Bisabolol, Ammonium Polyacryloyldimethyl Taurate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dipropylene Glycol, Squalane, Laminaria Japonica Extract, Eclipta Prostrata Leaf Extract, 3-O-Ethyl Ascorbic Acid, Glutathione, Ethylhexylglycerin, Fragrance, Lavandula Angustifolia (Lavender) Oil, Coptis Japonica Root Extract, Xanthan Gum, Butylene Glycol, Adenosine, Fructooligosaccharides, Sorbitan Isostearate, T-Butyl Alcohol, Hydrogenated Lecithin, Beta-Glucan, Hydrolyzed Hyaluronic Acid, Ascorbic Acid, Tocopherol, Allantoin, Ceramide NP, Oryza Sativa (Rice) Bran Oil, Oryza Sativa (Rice) Bran Extract, Glyceryl Stearate, Phytosphingosine, Cholesterol, Ceramide AP, Ceramide AS, Ceramide NS, Caprylyl Glycol, Ceramide NG, Ceramide EOP, Linalool, Limonene

(8) Additionally, Frag 176-191 may inhibit acetyl-CoA carboxylase, an enzyme associated with fatty acid synthesis, potentially limiting new adipose accumulation
Arienti, G., Ramacci, M
Diagnostic Methods Diagnosis typically involves measuring plasma carnitine levels and identifying mutations in the relevant genes through genetic testing